Timothy Weeden

Vice President- Head of Platform Discovery at Dyne Therapeutics

Speaker

Tim Weeden is a leading researcher in the field of oligonucleotide therapeutics, with over 20 years of experience in the discovery and development of small molecules, peptides, and antibody therapeutics across areas of immunology and rare disease. He initiated research efforts focused on the design of the FORCE^TM platform at Dyne Therapeutics and leads the broader implementation of pipeline and second-generation products. Tim has over 50 issued patents and authored a number of peer-reviewed articles published in leading scientific journals. Tim holds a B.S. degree in Biochemistry from Bridgewater State University.